PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 4, 2007Stroke174 citations

Lipoprotein (a) and Stroke

BSBarbara SmoldersRLRobin LemmensVTVincent Thijs

Key Result

Elevated lipoprotein (a) levels were associated with a 22% increased risk of incident stroke in the highest tertile compared to the lowest tertile.

Structured PICO

Does elevated Lipoprotein (a) increase the risk of incident stroke in the general population?

P
Population
Subjects in observational studies (case-control, nested case-control, and cohort) assessing the relationship between Lipoprotein (a) and cerebrovascular disease
I
Intervention
Elevated Lipoprotein (a) levels (e.g., highest tertile or >30 mg/L)
C
Comparator
Lower Lipoprotein (a) levels (e.g., lowest tertile or normal levels)
O
Outcome
Incident stroke (fatal and nonfatal cerebrovascular disease)hard clinical

Elevated Lipoprotein (a) is a modest but significant independent risk factor for incident stroke, particularly demonstrated in prospective cohort studies.

Limitations

  • High heterogeneity in case-control studies
  • Different measurement methods and cut-offs for Lp(a)
  • Use of arithmetic means instead of geometric means in some studies
  • Stroke subtypes not uniformly reported
  • Few studies examined patients with a stroke history

Abstract

Background and Purpose— The relationship between elevated lipoprotein (a) levelsLp(a) and stroke is controversial. We systematically reviewed the literature to determine whether Lp(a) is a risk factor for stroke. Methods— We searched MEDLINE (1966 to 2006), EMBASE (1974 to 2006), and Google scholar for articles on Lp(a) and cerebrovascular disease. From potentially relevant references retrieved, we excluded uncontrolled studies, studies of children with stroke, studies investigating carotid atherosclerosis, and studies lacking adequate data. Results— Thirty-one studies comprising 56 010 subjects with >4609 stroke events met all inclusion criteria and were included in the meta-analysis. In case-control studies (n=23 with 2600 strokes) unadjusted mean Lp(a) was higher in stroke patients (standardized mean difference, 0.39; 95% CI, 0.23 to 0.54) and was more frequently abnormally elevated (OR, 2.39; 95% CI, 1.57 to 3.63). Sensitivity analysis and meta-regression did not find any influence of study design, measurement period of Lp(a) in relationship to stroke episode, subtype, age, and sex to explain the substantial heterogeneity between studies (I 2 =83.7%; P 1645 strokes), incident stroke was more frequent in patients in the highest tertile of Lp(a) distribution compared with the lowest tertile of Lp(a) (RR, 1.22; 95% CI, 1.04 to 1.43). There was no publication bias or heterogeneity in the prospective studies (I 2 =0.00%; P =0.67). Conclusion— This meta-analysis suggests that elevated Lp(a) is a risk factor for incident stroke.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Smolders et al. (2007) studied this question. Elevated lipoprotein (a) levels were associated with a 22% increased risk of incident stroke in the highest tertile compared to the lowest tertile.

synapsesocial.com/papers/697b244d7c5eddd1a1489a58https://doi.org/10.1161/strokeaha.106.480657
Ask AI
Helpful
Bookmark
Share
View Full Paper